Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Presentation TCT 2017

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Presenter: Peter P. Monteleone, Thomas M. Tu, Jay S. Giri

November 01, 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

The Growing Population of Heart Failure and Care Variability

Presentation CHIP Seattle 2017

The Growing Population of Heart Failure and Care Variability

Presenter: Claudius Mahr

August 10, 2017

Ischemic Cardiomyopathy: Medical Therapy and Devices

Presentation CHIP Seattle 2017

Ischemic Cardiomyopathy: Medical Therapy and Devices

Presenter: Ryan C. Martin

August 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.